Public Employees Retirement System of Ohio Reduces Stake in Encompass Health Co. (NYSE:EHC)

Public Employees Retirement System of Ohio lessened its stake in shares of Encompass Health Co. (NYSE:EHC) by 8.3% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 41,046 shares of the company’s stock after selling 3,692 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Encompass Health were worth $3,967,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. UMB Bank n.a. grew its stake in Encompass Health by 387.7% during the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after acquiring an additional 252 shares in the last quarter. V Square Quantitative Management LLC boosted its holdings in Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares during the period. Avior Wealth Management LLC purchased a new position in shares of Encompass Health during the 3rd quarter valued at $40,000. Benjamin F. Edwards & Company Inc. increased its holdings in shares of Encompass Health by 58.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after purchasing an additional 198 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in Encompass Health during the second quarter valued at $58,000. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Price Performance

EHC stock opened at $98.19 on Monday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a market cap of $9.89 billion, a P/E ratio of 23.72, a P/E/G ratio of 1.34 and a beta of 0.86. The firm’s fifty day moving average is $99.35 and its 200 day moving average is $92.61. Encompass Health Co. has a 52 week low of $65.33 and a 52 week high of $104.55.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.94 by $0.09. The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The company’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.86 earnings per share. Research analysts predict that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

Wall Street Analyst Weigh In

Several research firms have weighed in on EHC. Truist Financial reaffirmed a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Royal Bank of Canada raised their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Barclays boosted their price target on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. KeyCorp lifted their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, UBS Group increased their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. Nine research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.